•91.3% vaccine efficacy observed against COVID-19, measured seven days through up to six months after the second dose
•100% effective in preventing COVID-19 cases in South Africa, where the B.1.351 lineage is prevalent!
Pfizer’s vaccine was 100% effective in preventing severe disease as defined by the U.S. Centers for Disease Control and Prevention and 95.3% effective in preventing severe disease as defined by the U.S. Food and Drug Administration. This is AMAZING. pfizer.com/news/press-rel…
This does NOT mean the vaccine is only effective for 6 months. It means that at the 6 month mark this level of high protection is still present! Vaccine safety now evaluated in more than 44,000 participants 16 years of age and older, with more than 12,000 vaccinated participants
at least six months follow-up after their second dose. Efficacy was consistent across age, gender, race and ethnicity demographics, and those with a variety of underlying conditions. NO serious safety concerns were observed in participants up to six months after the second dose.
So everyone is on the same page, these are updated topline results of trial participants from their pivotal Phase 3 study through March 13, 2021. Hence they are six months out from their second dose. Again, this DOES NOT mean the vaccine is only effective for six months.
With this data, Pfizer can now seek full approval of their vaccine. According to their CEO, the data confirms the favorable efficacy and safety profile of their vaccine and positions then to submit a Biologics License Application to the U.S. FDA. 6abc.com/pfizer-covid-v…
• • •
Missing some Tweet in this thread? You can try to
force a refresh
This is fantastic. Research out of Israel shows there have NOT been ANY vaccine-resistant SARS-CoV-2 variants found in the population. Comparing the prevalence of differing variants in the vaccinated and unvaccinated population, no difference was detected. ynetnews.com/health_science…
Remember, vaccines are preventives, not cures! Some people will get infected despite being vaccinated or recovered as no vaccine is 100% effective (but remember it will protect you from the worst of it all). Researchers observed if these individuals were disproportionately being
infected by a vaccine-resistant variant. They were not! Indeed there are variants, and E484K variants in the population. While still in the early days of their vaccination program, the variants do not appear to be gaining any advantage which means the vaccines are stopping them!
Vaccines are preventives, not cures. Immunity is not instantaneous. It is important to realize that vaccinated people who do get infected tend to only have mild or even asymptomatic cases of COVID-19, and don’t require hospitalization. This means the vaccines are indeed working.
With this said, when we see cases rising, or cases of reinfection, especially in places that have had a very robust vaccination program, we have to realize there is a period of time (~14 days after your 2nd dose) where you are considered “fully vaccinated.” It doesn’t just happen
with the snap of a finger. This is why it is still important for you to wear your mask after getting vaccinated. Masks and social distancing will not be forever, believe me, but this is not the time to let up. It is important for you to know there is an end in sight.
•Antibodies from infected and vaccinated individuals bind to the B.1.351 RBD
•Convalescent sera through eight months can neutralize the B.1.351 variant
•Serum from vaccinated individuals retain neutralization against the B.1.351 variant cell.com/cell-host-micr…
Researchers compared antibody binding and live virus neutralization of sera from individuals naturally infected and Moderna vaccinated individuals against two SARS-CoV-2 variants: B.1 containing the spike mutation D614G and variant B.1.351 containing additional spike mutations
and deletions. Researchers found that sera from acutely-infected and convalescent COVID-19 patients exhibited a 3-fold reduction in binding antibody titers to variant B.1.351’s receptor binding domain of the spike protein and a 3.5-fold reduction in neutralizing antibody titers
RIP my notifications. I swear I’ll read everything when I can. No, I didn’t think I would end up in the news from across the pond. I was just trying to put out the right facts for everyone. Give me a little time and I will answer everyone. Thank you.
One thing I do want to say. If all you have to insult me on is my name or my profile pic rather than the science I share, that says a lot more about you than it does me, trust me. Also, no, I didn’t target anyone. I was very polite, so you can all stop playing white knights now.
Good morning. ☀️ I wanted to thank everyone for the support. It means a lot to me. I think I confused some people and I apologize. I’m not going anywhere, and no article put me in a bad light, it was more so my notifications were too much to keep up with at once while at work.
A study finds vaccination boosts cross-variant neutralizing antibodies elicited by previous SARS-CoV-2 infection. Immunization generated B and CD4+ T-cell responses AND a 1000-fold increase in neutralizing antibody titers against B.1.351!🧵 science.sciencemag.org/content/early/…
Researchers examined whether sera from recovered and naïve donors collected prior to, and following immunizations with existing mRNA vaccines, could neutralize the Wuhan-Hu-1 and B.1.351 variants. Pre-vaccination sera from recovered donors neutralized Wuhan-Hu-1 and sporadically
neutralized B.1.351, but a SINGLE immunization boosted neutralizing titers against all variants and SARS-CoV-1 by up to 1000-fold. Neutralization was due to antibodies targeting the RBD and was not boosted by a second immunization in recovered donors.
AstraZeneca’s data from their clinical trials in the U.S. along with studies in Chile and Peru now in sync with the Data and Satety Monitoring Board is here!
•76% effective against symptomatic COVID-19
•100% effective against severe illness
•No safety concerns reported
Comparable efficacy result across ethnicity and age. 85% efficacy in participants aged 65+. These were 4-week dose interval. astrazeneca.com/media-centre/p…
Want to emphasize again, this efficacy was achieved using a 4-week dosing interval. The 12-week dosing interval used in the UK doubles levels of neutralizing antibodies, further increasing protection, hence results could have had the potential to be higher.